Skip to main content
logo
InnoCare Pharma Limited (HKG:9969)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
13.11
+0.71 (5.73%)
At close: Mar 27, 2026

InnoCare Pharma Revenue

In the year 2025, InnoCare Pharma had annual revenue of 2.37B CNY with 135.27% growth. InnoCare Pharma had revenue of 1.26B in the quarter ending December 31, 2025, with 304.10% growth.

Revenue
2.37B CNY
Revenue Growth
+135.27%
P/S Ratio
9.99
Revenue / Employee
2.02M CNY
Employees
1,176
Market Cap
26.41B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.37B1.37B135.27%
Dec 31, 20241.01B270.91M36.68%
Dec 31, 2023738.54M113.13M18.09%
Dec 31, 2022625.40M-417.63M-40.04%
Dec 31, 20211.04B1.04B76,368.70%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Genscript Biotech7.47B
Shanghai Henlius Biotech7.42B
Zai Lab3.58B
Shanghai Junshi Biosciences2.78B
Duality Biotherapeutics2.06B
Biocytogen Pharmaceuticals (Beijing)1.53B
Keymed Biosciences955.73M
Ascentage Pharma Group International428.02M
Revenue Rankings

InnoCare Pharma News

More News